Schedule 13D ownership disclosure
AEGLEA BIOTHERAPEUTICS INC
Security class unavailable · CUSIP: 00773J103
Event date: 2021-02-23
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,892,533
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-21-032826
- Form type
- SC 13D
- Filer
- Spyre Therapeutics, Inc.
- CIK
- CIK 1636282
- Filed
- Mar 05, 2021
- Reporting period
- Feb 23, 2021
- Description
- Schedule 13D beneficial ownership